Back to results
US 2025/0082783 A1Published application
Compositions and methods for prevention and treatment of genetic disease
AssigneeChildren's Medical Center Corporation
InventorDario O. Fauza
Life of this patent
Estimating the term…
Abstract
Methods and compositions for the transamniotic delivery of mRNA encoding cystic fibrosis transmembrane conductance regulator protein or surfactant protein B to a fetus for the prenatal treatment of cystic fibrosis or a surfactant protein B deficiency.
Claims20
A method for treating cystic fibrosis in a developing fetus, the method comprising:
- administering to the amniotic fluid surrounding a developing fetus an mRNA molecule encoding a cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide, thereby treating cystic fibrosis in the developing fetus.
A method for treating a disease or disorder associated with a surfactant protein B (SPB) deficiency in a developing fetus, the method comprising:
- administering to the amniotic fluid surrounding a developing fetus an mRNA molecule encoding an SPB polypeptide, thereby treating the disease or disorder associated with SPB deficiency in the developing fetus.
A method for delivering one or more mRNA molecules to the bloodstream of a developing fetus, the method comprising:
- administering to the amniotic fluid surrounding the developing fetus an mRNA molecule encoding a polypeptide that has reduced expression and/or activity in the developing fetus relative to a healthy developing fetus.
Dependencies are inferred from the claim text.